Fidelity Investments’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26.8K Sell
1,536
-4,182
-73% -$83K ﹤0.01% 4396
2025
Q4
$112K Buy
5,718
+2,528
+79% +$52.4K ﹤0.01% 3701
2025
Q3
$87.9K Sell
3,190
-164
-5% -$5.05K ﹤0.01% 3721
2025
Q2
$102K Buy
3,354
+472
+16% +$13.4K ﹤0.01% 3603
2025
Q1
$77.7K Buy
2,882
+1,523
+112% +$48.2K ﹤0.01% 3671
2024
Q4
$48.8K Buy
1,359
+432
+47% +$16.2K ﹤0.01% 3867
2024
Q3
$35.1K Sell
927
-41
-4% -$1.69K ﹤0.01% 3931
2024
Q2
$43.8K Buy
968
+513
+113% +$23.6K ﹤0.01% 3682
2024
Q1
$22.1K Buy
455
+31
+7% +$1.52K ﹤0.01% 3975
2023
Q4
$22.7K Sell
424
-671
-61% -$33.9K ﹤0.01% 3880
2023
Q3
$64.2K Sell
1,095
-19
-2% -$1.19K ﹤0.01% 3269
2023
Q2
$70.2K Buy
1,114
+57
+5% +$3.63K ﹤0.01% 3296
2023
Q1
$66.5K Buy
1,057
+441
+72% +$26.3K ﹤0.01% 3332
2022
Q4
$32.8K Buy
616
+301
+96% +$16.3K ﹤0.01% 3597
2022
Q3
$18K Sell
315
-23,246
-99% -$1.54M ﹤0.01% 3897
2022
Q2
$1.71M Sell
23,561
-5,845
-20% -$435K ﹤0.01% 2547
2022
Q1
$2.34M Sell
29,406
-2,547
-8% -$230K ﹤0.01% 2562
2021
Q4
$3.23M Sell
31,953
-81
-0.3% -$8.08K ﹤0.01% 2461
2021
Q3
$2.95M Buy
32,034
+27,197
+562% +$2.62M ﹤0.01% 2488
2021
Q2
$495K Buy
4,837
+4,814
+20,930% +$483K ﹤0.01% 2773
2021
Q1
$2K Hold
23
﹤0.01% 3754
2020
Q4
$2K Hold
23
﹤0.01% 3623
2020
Q3
$2K Hold
23
﹤0.01% 3500
2020
Q2
$2K Hold
23
﹤0.01% 3401
2020
Q1
$1K Hold
23
﹤0.01% 3540
2019
Q4
$2K Sell
23
-151
-87% -$11.1K ﹤0.01% 3588
2019
Q3
$13K Sell
174
-387,898
-100% -$26M ﹤0.01% 3181
2019
Q2
$30.8M Buy
388,072
+352,129
+980% +$27.9M ﹤0.01% 1437
2019
Q1
$3.02M Sell
35,943
-230
-0.6% -$24K ﹤0.01% 2211
2018
Q4
$4.26M Sell
36,173
-2,221
-6% -$257K ﹤0.01% 2090
2018
Q3
$4.63M Sell
38,394
-201,049
-84% -$25M ﹤0.01% 2183
2018
Q2
$27.6M Sell
239,443
-737,802
-75% -$80.7M ﹤0.01% 1564
2018
Q1
$83.9M Sell
977,245
-572,325
-37% -$44.3M 0.01% 1052
2017
Q4
$115M Sell
1,549,570
-48,826
-3% -$3.27M 0.01% 933
2017
Q3
$92.2M Buy
1,598,396
+253
+0% +$14.9K 0.01% 1007
2017
Q2
$102M Buy
1,598,143
+60,033
+4% +$3.7M 0.01% 976
2017
Q1
$88.6M Buy
1,538,110
+102,086
+7% +$6.09M 0.01% 1038
2016
Q4
$87.9M Buy
1,436,024
+21,852
+2% +$1.42M 0.01% 1059
2016
Q3
$97.8M Buy
1,414,172
+8,148
+0.6% +$537K 0.01% 988
2016
Q2
$78.3M Sell
1,406,024
-200
-0% -$12.1K 0.01% 1087
2016
Q1
$85.4M Sell
1,406,224
-1,294
-0.1% -$76.2K 0.01% 1030
2015
Q4
$89.9M Sell
1,407,518
-9,682
-0.7% -$628K 0.01% 1009
2015
Q3
$95M Sell
1,417,200
-589,514
-29% -$41.7M 0.01% 973
2015
Q2
$137M Buy
2,006,714
+6,714
+0.3% +$426K 0.02% 881
2015
Q1
$111M Sell
2,000,000
-293,696
-13% -$15.1M 0.01% 981
2014
Q4
$118M Sell
2,293,696
-956,304
-29% -$47M 0.02% 922
2014
Q3
$120M Hold
3,250,000
0.02% 885
2014
Q2
$127M Sell
3,250,000
-118
-0% -$4.38K 0.02% 870
2014
Q1
$122M Buy
3,250,118
+50,084
+2% +$1.75M 0.02% 873
2013
Q4
$121M Buy
3,200,034
+34
+0% +$1.3K 0.02% 862
2013
Q3
$139M Sell
3,200,000
-700,222
-18% -$28.1M 0.02% 792
2013
Q2
$141M Buy
+3,900,222
New +$119M 0.02% 744

Other funds holding USNA

Fidelity Investments's USNA Position: Q1 2026 in Review

Fidelity Investments reduced its Usana Health Sciences (USNA) stake by 73% in Q1 2026, selling an estimated $83K and leaving 1,536 shares worth $26.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4396.

Fidelity Investments first reported a position in USNA in Q2 2013 and has held it in 52 quarters since. The position peaked at $141M in Q2 2013. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

  • Fidelity Investments held 1,536 shares of Usana Health Sciences worth $26.8K as of Q1 2026.
  • Fidelity Investments sold 4,182 Usana Health Sciences shares in Q1 2026, an estimated $83K.
  • Usana Health Sciences made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #4396 holding.
  • Fidelity Investments first reported a position in Usana Health Sciences in Q2 2013 and has held it in 52 quarters since.
  • Fidelity Investments's Usana Health Sciences position peaked at $141M in Q2 2013.
  • 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.